BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire G, Kelly PM, Anstey NM, Ralph AP. Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups. PLoS One 2013;8:e76077. [PMID: 24086690 DOI: 10.1371/journal.pone.0076077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis. BMC Med 2018;16:73. [PMID: 29779492 DOI: 10.1186/s12916-018-1053-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
2 Ralph AP. l-Arginine in Pulmonary Tuberculosis. L-Arginine in Clinical Nutrition 2017. [DOI: 10.1007/978-3-319-26009-9_47] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Meghji J, Simpson H, Squire SB, Mortimer K. A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease. PLoS One 2016;11:e0161176. [PMID: 27518438 DOI: 10.1371/journal.pone.0161176] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
4 Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire GP, Kelly PM, Anstey NM. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One 2013;8:e80302. [PMID: 24312209 DOI: 10.1371/journal.pone.0080302] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]